$MRK Recent News Merck, McDonald's are top decliners in

New Post Public Reply Private Reply Replies (0) Message Board

Dec 4, 2013 at 4:23 PM

$MRK Recent News

Merck, McDonald's are top decliners in Dow index 18 min ago - Polya Lesova
Cuts, stock buyback, acquisition combine to boost Forest shares 11:09 a.m. Dec. 2, 2013 - blogs.marketwatch.com
Merck, J.P. Morgan lead Dow decliners 9:35 a.m. Nov. 13, 2013 - Laura Mandaro
Merck, Cisco lead gainers in Dow industrials 4:03 p.m. Nov. 12, 2013 - Polya Lesova
Bitcoin buying for dummies 3:22 p.m. Nov. 12, 2013 - blogs.marketwatch.com
Planned layoffs up 13.5% in October: Challenger 7:30 a.m. Nov. 6, 2013 - Steve Goldstein
Newscast: S&P 500 notches year's 32nd record high 8:08 p.m. Oct. 28, 2013 - MarketWatch
J.C. Penney, Bristol-Myers top S&P 500 7:08 p.m. Oct. 28, 2013 - Saumya Vaishampayan
S&P up for 8th day in 9; Dow, Nasdaq flat 4:57 p.m. Oct. 28, 2013 - Victor Reklaitis
Newscast: Stocks mixed after lackluster day 4:26 p.m. Oct. 28, 2013 - MarketWatch
Newscast: Car reliability ranks get new members 2:28 p.m. Oct. 28, 2013 - MarketWatch
Merck shares stumble on earnings weakness, talk of divesting assets 10:58 a.m. Oct. 28, 2013 - blogs.marketwatch.com
Merck, down 2.2%, leads Dow average lower 9:34 a.m. Oct. 28, 2013 - Laura Mandaro
Stock futures continue to waver after data 9:30 a.m. Oct. 28, 2013 - Sara Sjolin
Apple is Monday’s stock to watch as results loom 8:21 a.m. Oct. 28, 2013 - Sue Chang
Merck profit down 35% as Singulair sales fall 7:25 a.m. Oct. 28, 2013 - MarketWatch.com
Merck third-quarter profit, revenue fall 7:17 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck narrows 2013 EPS guidance; holds sales view 7:10 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck Q3 adj. EPS edges down to $0.92 vs. $0.95 7:03 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck Q3 sales down to $11.03 bln vs. $11.49 bln 7:03 a.m. Oct. 28, 2013 - Saumya Vaishampayan

Merck, Procter & Gamble Fall as Market Shrugs Off Taper Fears 6 min ago - TheStreet.com
Biotech Stock Predictions 2014: Vertex is Bought, Alexion Sinks, BlueBird Flies And More 11:35 a.m. Today - TheStreet.com
Meet the Preliminary 2014 Dogs of the Dow: Dividends Galore 11:09 a.m. Today - 247WallSt.com
Health Care Heartiest, Gold Funds All Red In November 5:41 p.m. Dec. 3, 2013 - Investors Business Daily
Forest Labs Up on Strategic Initiatives - Analyst Blog 1:25 p.m. Dec. 3, 2013 - Zacks.com
4 Reasons Tonix Could Be A Multi-Bagger 10:30 a.m. Dec. 3, 2013 - Seeking Alpha
Will GlaxoSmithKline Head Higher After Recent Headlines? 8:53 a.m. Dec. 3, 2013 - Wall St. Cheat Sheet
Pharma & Biotech Stock Outlook - Dec 2013 - Zacks Analyst Interviews 4:28 a.m. Dec. 3, 2013 - Zacks.com
Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook 4:28 a.m. Dec. 3, 2013 - Zacks.com
Forest Labs to Cut 500 Jobs in Restructuring 7:31 p.m. Dec. 2, 2013 - WSJ.com
Merck and Seadrill Top GuruFocus Dividend Growers of the Week 4:56 p.m. Dec. 2, 2013 - GuruFocus.com
Merck: The Good, The Bad And The Ugly 2:46 p.m. Dec. 2, 2013 - Seeking Alpha
Today's Momo Momentum Stock To Watch: Merck (MRK) 1:59 p.m. Dec. 2, 2013 - TheStreet.com
Forest Labs acquires rights to schizophrenia treatment from Merck 10:11 a.m. Dec. 2, 2013 - Seeking Alpha
Losing Some Sparkle to Buybacks 3:10 a.m. Nov. 30, 2013 - Barrons.com
Merck's Noxafil Tablets Approved by the FDA - Analyst Blog 11:30 a.m. Nov. 29, 2013 - Zacks.com
Buy Today: Merck & Co Inc's Buy Recommendation Reiterated 9:00 a.m. Nov. 29, 2013 - TheStreet.com
Drug Stocks: Winners, Losers, in Statin Shift 10:41 p.m. Nov. 27, 2013 - Barrons.com
Updated statin guidelines give AstraZeneca the upper hand: Barron's 10:54 a.m. Nov. 27, 2013 - Seeking Alpha
GlaxoSmithKline: What's The Next Growth Driver? 2:38 p.m. Nov. 26, 2013 - Seeking Alpha

Increased Quarterly Dividends, HIV Elimination Efforts, Advanced Treatment Options, and Conference Participations - Research Report on Merck, Varian, Mylan, Achillion, and Abiomed 8:00 a.m. Today - PR Newswire
Intarcia Therapeutics Appoints Nancy Thornberry to Board of Directors 2:37 p.m. Dec. 2, 2013 - PR Newswire
Forest to Acquire U.S. Marketing Rights to Saphris(R) (asenapine) from Merck 9:00 a.m. Dec. 2, 2013 - BusinessWire
EMD Serono's New Spin-off TocopheRx to Focus on Infertility Treatment 8:30 a.m. Dec. 2, 2013 - BusinessWire
FDA Approvals, Stock Price Updates, New Study Results, Conference Schedules and Partnerships - Research Report on Merck, Pharmacyclics, UnitedHealth Group, Medtronic, and AstraZeneca 8:00 a.m. Nov. 29, 2013 - PR Newswire
Merck Announces Increased Quarterly Dividend 2:18 p.m. Nov. 26, 2013 - BusinessWire
FDA Approves Merck's NOXAFIL(R) (posaconazole) Delayed-Release Tablets 9:00 a.m. Nov. 26, 2013 - BusinessWire
Stock Price Movements and Program Launches Reported by Healthcare Companies - Research Report on Merck, Abiomed, Alere, Raptor Pharmaceuticals and West Pharmaceutical Services 8:00 a.m. Nov. 26, 2013 - PR Newswire
SiSense Wins Quarter Million Dollar Prize, Takes Top Honor in "Take the H.E.L.M." Competition 11:30 a.m. Nov. 25, 2013 - PR Newswire
Mondo Guerra and the Merck HIV Educational Campaign I Design Invite the Community to Pledge Action in Honor of World AIDS Day 8:01 a.m. Nov. 25, 2013 - PR Newswire
ARMO BioSciences Initiates Phase 1 Clinical Trial of First-In-Class Cancer Immunotherapy 8:00 a.m. Nov. 25, 2013 - PR Newswire
European Patent Office Issues Decision Regarding Universal Display's Organometallic Iridium Patent 9:01 a.m. Nov. 22, 2013 - BusinessWire
Sixth Annual Biotech Showcase(TM) Returns to San Francisco January 13-15 6:51 p.m. Nov. 21, 2013 - BusinessWire
FDA Approvals, Stock Price Movements, and Study Results - Research Report on Pfizer, Celgene, Merck, Quest Diagnostics, and Pharmacyclics 8:00 a.m. Nov. 21, 2013 - PR Newswire
Merck Consumer Health Turnaround on Track 4:00 a.m. Nov. 21, 2013 - BusinessWire
Critical Alerts For Netflix, Salesforce.com, Goldman Sachs, Merck, and Valero Energy Released By InvestorsObserver 9:31 a.m. Nov. 19, 2013 - PR Newswire
Merck for Mothers Working to End the Tragedy of Women in America Dying in Childbirth and Pregnancy 8:30 a.m. Nov. 19, 2013 - PR Newswire
Additional Interim Data for Merck's Investigational Anti-PD-1 Immunotherapy, MK-3475, Shows Estimated Overall Survival Rate of 81 Percent at One Year in Patients with Advanced Melanoma 12:00 p.m. Nov. 18, 2013 - BusinessWire
Merck Partners With TRUSTe to Become Certified Under APEC Cross Border Privacy Rules 9:00 a.m. Nov. 18, 2013 - Marketwire
Merck's New Drug Application for an Investigational Intravenous (IV) Formulation of NOXAFIL(R) (posaconazole) Receives FDA Priority Review 8:30 a.m. Nov. 18, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

DUNKMAN's Slam Dunk Expansion Plans for 2027

More Than Just A Dunk Contest You ever heard of a slam dunk that turns into something bigger than the game itself? Well, Shaquille O'Neal's DUNKMAN is proving just that. Born from the vision of O'Neal and Authentic Brands Group, this beast of an entity isn't just about dunks anymore—it's a whole darn league carving out space in the sporting world. From Inaugural Sparks...

Zum Drivers Shine as New School Year Begins

Opening the School Year with High Hopes Zum's crew of enthusiastic drivers hit the streets with a mission: kickstarting the new school year with a sense of excitement that feels fresh, even to a grizzled trader like me. These folks are doing more than just turning the ignition, they’re handling a vital cog in the education machine. From Fresno down to Rockford, you’ll...

Corgi Re Modernizes Reinsurance with Tech-Focus

Amidst the hullabaloo of the reinsurance world, Corgi Insurance is attempting something rather bold. They're flinging open the doors to innovation with a new brainchild, Corgi Re, promising to shake off the dust from an industry that still clings to the bygone era of spreadsheets and marathon underwriting cycles. The aim? Fire up modern underwriting technology and...

Costa Rica's Summit Draws Global Investors, Buyers

Costa Rica's Big Stage for Business and Opportunity You might look at Costa Rica and think of lush rainforests and coffee beans, but right now, it's a hub bustling with suits, spreadsheets, and strategic meetings. Over three days, the Costa Rica Trade & Investment Summit (CRTIS) gathered nearly half a thousand buyers and investors all under one roof in San José. Local...

TETRA Technologies to Engage at Key Investor Events

Revving Up for Major Investor Conferences All eyes are on TETRA Technologies Inc. (NYSE:TTI) as they gear up to make splashy appearances at not one, but two high-profile investor conferences in New York. It's setting the stage for some potentially juicy conversations about where TTI, a player with deep roots in energy services, is heading in this whirlwind of an industry....

PLAY Palm Angels Launches at Pacsun with Avani Gregg

Revamping Streetwear with PLAY Palm Angels and Pacsun In a move that's making waves from the fashion runways straight into the heart of youth culture, PLAY Palm Angels is swooping into Pacsun, and they’re not just strolling in—they’re parading with a 41-piece fashion collection. Not to mention, they've snagged Avani Gregg, a powerhouse cultural influencer, to strut...

RealityMine Appoints CPO Amidst Strong Growth Momentum

Pushing the Boundaries of Behavioral Data When a company like RealityMine posts a whopping 75% year-over-year revenue bump, you know they're not here to mess around. Enter Soumya Bijjal, a seasoned pro stepping in as their inaugural Chief Product Officer. This isn't just about adding to the C-suite boys' club; it's about locking in on a goldmine of behavioral data that's...

Acer's New Monitors: ePaper, Triple Displays & More

Next-Gen Screens: Breakthrough or Bust? So, Acer’s stepping up its game, unveiling an armory of gadgets designed to cement their spot in the tech arena. On the menu today? ePaper displays and enhanced connectivity gizmos that could either tip the scales or sink like a stone. Keep your eyes peeled, though—these updates aren't just another throwaway press release....

Mitrade EU Enhances Investor Safety with New Insurance

Mitrade's New Insurance: A Safety Net? Mitrade EU is amping up its game with some fresh insurance perks that catch the eye. They're slapping on some extra insolvency protection for clients trading under their CySEC license. Now that sounds like a financial shield anyone would want. Basically, they're adding another layer to the basic regulatory protections, and without...

Intrigue Over Guadalupe River Property Bid

Straight up, a chance like this doesn't float by every day. The Guadalupe River portfolio, with its mix of entertainment, hospitality, and commercial assets up for grabs in New Braunfels, Texas, is the talk of the investor town. If you've got deep pockets and a keen eye for opportunities, you're gonna want a piece of this pie before the September 22 bid deadline hits. The...